Skip to main content
Toggle navigation
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
D
D'Agostino, Mattia
Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
(OA-25) High Accuracy of Next-Generation Flow (NGF) in Predicting Measurable Residual Disease by Next-Generation Sequencing (NGS) in the 10−6 Range: A Prospective Comparison Within the Phase III IsKia Trial
Location: Room 718
Mattia D'Agostino
Davies, Faith
Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
Risk assessment of newly diagnosed MM: genetic and biological risk factors
Location: Hall FG
Faith Davies
Derman, Ben
University of Chicago
Meet the Experts: MRD in clinical practice
Location: Room 714B
Ben Derman
Dhakal, Binod
Medical College of Wisconsin
(OA-52) Updated Results of a Phase 1 First-in-Human Study of Cemsidomide (CFT7455), a Novel MonoDAC® Degrader, with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Location: Room 701
Binod Dhakal
(OA-60) Updated Interim Results of Sonrotoclax + Dexamethasone in Patients With t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (R/R MM): An All-Oral Treatment
Location: Room 701
Binod Dhakal
Optimizing Patient Selection and the CAR-T Patient Journey for RRMM
Location: Hall FG
Binod Dhakal
Dhodapkar, Madhav
Fred Hutch Cancer Center, Seattle, WA
Microenvironment
Location: Hall FG
Madhav Dhodapkar
Dimopoulos, Meletios
National and Kapodistrian University of Athens, Athens, Greece
Round Table discussion
Location: Hall FG
Meletios Dimopoulos
Dispenzieri, Angela
Mayo Clinic Rochester
Meet the Experts: Amyloidosis
Location: Room 716B
Angela Dispenzieri
Driscoll, James
Case Western Reserve University
(OA-34) Exploring Molecular Glues to Activate Proteasomes and Develop Shared and Personalized Neoantigen-Based Therapeutics in Multiple Myeloma
Location: Room 718
James Driscoll
Du, Chenxing
Institute of Hematology and Blood Diseases Hospital
(OA-16) BCMA CAR T-Cell Therapy in Newly Diagnosed Primary Plasma Cell Leukemia Ineligible for Transplantation: An Open Label, Single-arm, Phase 2 Study (CAREMM-002)
Location: Hall FG
Chenxing Du
